Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2017

Open Access 01-12-2017 | Case report

Successful management of retinal metastasis from renal cancer with everolimus in a monophthalmic patient: a case report

Authors: Ismail Essadi, Issam Lalya, Mohamed Kriet, Abdelhamid El Omrani, Rhizlane Belbaraka, Mouna Khouchani

Published in: Journal of Medical Case Reports | Issue 1/2017

Login to get access

Abstract

Background

The retina is an uncommon site for metastases, in particular from solid tumors. Some authors have reported a recent increase in the incidence of metastases in infrequent sites, such as brain or bone, probably due to the expanded treatment options and the resulting improved survival. Choroidal metastasis is the most common type of intraocular malignancy. The most common primary sites associated with choroidal metastasis are breast cancer in women and lung cancer in men. Treatment options are limited, but they must be discussed and adapted to the patient profile.

Cases presentation

We report a case of a 62-year-old Moroccan man with a history of monophthalmitis secondary to a war injury of 30 years’ duration. He has been followed for 28 months for metastatic clear-cell renal carcinoma. The first-line treatment was effective for 24 months, before disease progression as retinal metastasis and accentuation of lung metastases. A second-line treatment with everolimus resulted in marked improvement of symptoms, complete recovery of visual function, and partial response in retinal localization.

Conclusions

Choroidal metastasis of renal cancer is a rare situation that must be actively sought in order to arrive at a suitable therapeutic approach.
Literature
1.
go back to reference Kreusel KM, Bechrakis N, Wiegel T, et al. Clinical characteristics of choroidal metastasis [in German]. Ophthalmologe. 2003;100:618–22.CrossRefPubMed Kreusel KM, Bechrakis N, Wiegel T, et al. Clinical characteristics of choroidal metastasis [in German]. Ophthalmologe. 2003;100:618–22.CrossRefPubMed
2.
go back to reference Jardel P, Sauerwein W, Olivier T, et al. Management of choroidal metastases. Cancer Treat Rev. 2014;40:1119–28.CrossRefPubMed Jardel P, Sauerwein W, Olivier T, et al. Management of choroidal metastases. Cancer Treat Rev. 2014;40:1119–28.CrossRefPubMed
3.
go back to reference Leys AM, Van Eyck LM, Nuttin BJ, et al. Metastatic carcinoma to the retina: clinicopathologic findings in two cases. Arch Ophthalmol. 1990;108(10):1448–52.CrossRefPubMed Leys AM, Van Eyck LM, Nuttin BJ, et al. Metastatic carcinoma to the retina: clinicopathologic findings in two cases. Arch Ophthalmol. 1990;108(10):1448–52.CrossRefPubMed
5.
go back to reference Shields CL, Shields JA. Choroidal and retinal metastasis. In: Arevalo JF, editor. Retinal and choroidal manifestations of selected systemic diseases. New York: Springer; 2013. p. 267–82.CrossRef Shields CL, Shields JA. Choroidal and retinal metastasis. In: Arevalo JF, editor. Retinal and choroidal manifestations of selected systemic diseases. New York: Springer; 2013. p. 267–82.CrossRef
6.
go back to reference Katsutoshi A, Akina K, Masanori M, et al. Factors affecting visual outcome in cases of lung cancer with choroidal metastasis initially presenting with ocular symptoms. Japanese Journal of Lung Cancer. 2011;51:94–8. Katsutoshi A, Akina K, Masanori M, et al. Factors affecting visual outcome in cases of lung cancer with choroidal metastasis initially presenting with ocular symptoms. Japanese Journal of Lung Cancer. 2011;51:94–8.
7.
go back to reference Kreusel KM, Bechrakis NE, Wiegel T, Krause L, Foerster MH. Incidence and clinical characteristics of symptomatic choroidal metastasis from lung cancer. Acta Ophthalmol. 2008;86(5):515–9.CrossRefPubMed Kreusel KM, Bechrakis NE, Wiegel T, Krause L, Foerster MH. Incidence and clinical characteristics of symptomatic choroidal metastasis from lung cancer. Acta Ophthalmol. 2008;86(5):515–9.CrossRefPubMed
8.
go back to reference Amer R, Pe’er J, Chowers I, Anteby I. Treatment options in the management of choroidal metastases. Ophthalmologica. 2004;218:372–7.CrossRefPubMed Amer R, Pe’er J, Chowers I, Anteby I. Treatment options in the management of choroidal metastases. Ophthalmologica. 2004;218:372–7.CrossRefPubMed
9.
go back to reference Demirci H, Shields CL, Chao AN, Shields JE. Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol. 2003;136:264–71.CrossRefPubMed Demirci H, Shields CL, Chao AN, Shields JE. Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol. 2003;136:264–71.CrossRefPubMed
10.
go back to reference Ali MJ, Honavar SG, Vemuganti GK, Singh AD. Fine needle aspiration biopsy of retinal tumors. Monogr Clin Cytol. 2012;21:72–81.CrossRefPubMed Ali MJ, Honavar SG, Vemuganti GK, Singh AD. Fine needle aspiration biopsy of retinal tumors. Monogr Clin Cytol. 2012;21:72–81.CrossRefPubMed
11.
12.
go back to reference Lumi K, Yuriko B, Yusuke Y, et al. A case of choroidal metastasis from small-cell lung carcinoma diagnosed through ocular symptoms [in Japanese]. Atarashii Ganka. 2009;26:1687–91. Lumi K, Yuriko B, Yusuke Y, et al. A case of choroidal metastasis from small-cell lung carcinoma diagnosed through ocular symptoms [in Japanese]. Atarashii Ganka. 2009;26:1687–91.
13.
go back to reference Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376:354–66.CrossRefPubMed Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376:354–66.CrossRefPubMed
14.
go back to reference Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A, RECORD-1 Study Group. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008;372(9637):449–56.CrossRefPubMed Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A, RECORD-1 Study Group. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008;372(9637):449–56.CrossRefPubMed
15.
go back to reference Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1803–13.CrossRefPubMed Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1803–13.CrossRefPubMed
16.
go back to reference Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, et al. Cabozantinib versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1814–23.CrossRefPubMedPubMedCentral Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, et al. Cabozantinib versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1814–23.CrossRefPubMedPubMedCentral
Metadata
Title
Successful management of retinal metastasis from renal cancer with everolimus in a monophthalmic patient: a case report
Authors
Ismail Essadi
Issam Lalya
Mohamed Kriet
Abdelhamid El Omrani
Rhizlane Belbaraka
Mouna Khouchani
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2017
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1501-2

Other articles of this Issue 1/2017

Journal of Medical Case Reports 1/2017 Go to the issue